Study S000648

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04324229
Acronym: Liragest
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: SINGLE
Status: ACTIVE_NOT_RECRUITING
Enrollment: 80
Start: 2020-02-07
Primary completion: 2024-09-30
Lead sponsor: Turku University Hospital
Conditions: Gestational Diabetes
Interventions: DRUG:Liraglutide 6 MG/ML [Victoza]; DRUG:Placebos
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Incidence of type 2 diabetes [from year 1 to 5]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.